104 related articles for article (PubMed ID: 302291)
1. Antibody of polyribophate of Haemophilus influenzae type b in infants and children: effect of immunization with polyribophosphate.
Anderson P; Smith DH; Ingram DL; Wilkins J; Wehrle PF; Howie VM
J Infect Dis; 1977 Aug; 136 Suppl():S57-62. PubMed ID: 302291
[TBL] [Abstract][Full Text] [Related]
2. Fetal-neonatal passive immunization against Hemophilus influenzae, type b.
Amstey MS; Insel R; Munoz J; Pichichero M
Am J Obstet Gynecol; 1985 Nov; 153(6):607-11. PubMed ID: 3877464
[TBL] [Abstract][Full Text] [Related]
3. Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response.
O'Reilly RJ; Anderson P; Ingram DL; Peter G; Smith DH
J Clin Invest; 1975 Oct; 56(4):1012-22. PubMed ID: 1099117
[TBL] [Abstract][Full Text] [Related]
4. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b.
Anderson P; Pichichero ME; Insel RA
J Pediatr; 1985 Sep; 107(3):346-51. PubMed ID: 3875705
[TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
6. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity in weanling rabbits of a polyribophosphate complex from Haemophilus influenzae type b.
Anderson P; Smith DH
J Infect Dis; 1977 Aug; 136 Suppl():S63-70. PubMed ID: 302292
[TBL] [Abstract][Full Text] [Related]
8. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.
Black SB; Shinefield HR; Lampert D; Fireman B; Hiatt RA; Polen M; Vittinghoff E
Pediatr Infect Dis J; 1991 Feb; 10(2):92-6. PubMed ID: 2062620
[TBL] [Abstract][Full Text] [Related]
10. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
Käyhty H; Karanko V; Peltola H; Mäkelä PH
Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
12. Haemophilus influenzae type b polysaccharide vaccines.
Granoff DM; Cates KL
J Pediatr; 1985 Sep; 107(3):330-6. PubMed ID: 3897497
[No Abstract] [Full Text] [Related]
13. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
14. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
Adderson EE; Chisholm N; Halperin SA
Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
[TBL] [Abstract][Full Text] [Related]
15. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
Parke JC; Schneerson R; Robbins JB; Schlesselman JJ
J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
17. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
18. Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.
Anderson P; Peter G; Johnston RB; Wetterlow LH; Smith DH
J Clin Invest; 1972 Jan; 51(1):39-44. PubMed ID: 4536615
[TBL] [Abstract][Full Text] [Related]
19. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants.
Campbell H; Byass P; Ahonkhai VI; Vella PP; Greenwood BM
Pediatrics; 1990 Jul; 86(1):102-7. PubMed ID: 2113671
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
